{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-095504","form_type":"8-K","ticker":null,"cik":"0001567892","company_name":"Keenova Therapeutics plc","filed_at":"2023-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.366219+00:00","generated_at":"2026-06-11T02:51:59.502200+00:00","sec_items":["1.03","2.04","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Mallinckrodt files prepackaged Chapter 11 to cut $1.9B debt; expects Q4 2023 emergence","bullets":["Filed prepackaged Chapter 11 on Aug 28, 2023, with support from >85% of first/second lien debtholders and opioid trust.","Plan reduces total funded debt by ~$1.9B; expects to emerge in Q4 2023.","Made final $250M payment to Opioid Master Disbursement Trust II on Aug 24, total $700M paid.","Will have >$450M liquidity (cash, $250M new financing, ABL availability) during Chapter 11.","Received grand jury subpoena from USAO Western Virginia on Aug 22 regarding controlled substance reporting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-095504","json":"https://secwatch.observer/filing/0001104659-23-095504.json","markdown":"https://secwatch.observer/filing/0001104659-23-095504.md","text":"https://secwatch.observer/filing/0001104659-23-095504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923095504/0001104659-23-095504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923095504/tm2324934d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:51:59.502200+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49cc5ef5c3420794e72742aa5104007449d197a3","claim":"Keenova Therapeutics plc entered chapter 11 in U.S. Bankruptcy Court for the District of Delaware (petition 2023-08-28).","evidence_excerpt":"on August 28, 2023 (the “Petition Date”), the Company and certain of its subsidiaries voluntarily initiated proceedings (the “Chapter 11 Cases”) under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923095504/0001104659-23-095504-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"U.S. Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2023-08-28"}],"fact_type":"distress_event"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}